Company news
Futureproofing the Fight Against COVID-19futureproofing the fight against COVID-19, how Fluidic Analytics technology is being used in the fight against COVID-19.
Latest news and insights
-
-
Company news
BBC showcases Fluidic Analytics' clinical collaboration with Prof AguzziRichard Westcott spent a day filming in our laboratories and interviewed both Andrew Lynn, CEO Fluidic Analytics, and Prof Adriano Aguzzi from University Hospital Zurich on the breakthrough in the fight against COVID-19.
-
Company news
Prof Aguzzi Joins our Clinical and Scientific Advisory BoardFluidic Analytics, a pioneer in protein interaction analysis, announced today the addition of Prof. Adriano Aguzzi to its Clinical and Scientific Advisory Board. Prof Aguzzi is an internationally recognized expert in the field of neuropathology and the architect of multiple clinical research programs focusing on the effects of proteins and protein interactions on clinical outcomes.
-
Company news
Fluidic Analytics launches new product to provide new insights into the immune response to COVID-19Fluidic Analytics, has announced the global launch of the Fluidity One-W Serum. The new instrument provides quantitative insights into the antibody response to COVID-19 that cannot easily be obtained with traditional antibody tests. The Fluidity One‑W Serum has been developed to allow researchers to characterize and quantify antigen-antibody interactions directly in minimally diluted blood serum.
-
Company news
Breakthrough protein analysis instrument – the Fluidity One-W – launches at PEGS Europe 2019Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system - the Fluidity One-W is set to revolutionize protein interaction analysis, and has been officially launched at PEGS Europe 2019.
-
Company news
Fluidic Analytics invites scientists to “Be the One-With a great idea” for a chance to win a 3-month instrument placementAhead of the launch of the Fluidity One-W, the new instrument for protein interaction analysis, Fluidic Analytics announces competition at ELRIG Drug Discovery 2019.
-
Events
Fluidic Analytics showcases protein analysis expertise across EuropeNew technologies for protein analysis to be presented at multiple events throughout Europe this autumn
-
Press and media, Company news
Fluidic Analytics welcomes Dr Joe Keegan as ChairmanFluidic Analytics Ltd, a pioneer in protein analysis, announces that Dr Joe Keegan is joining the company as Chairman. Joe brings over 30 years of experience in the life sciences industry and joins Fluidic at an exciting time of growth and expansion as the company prepares for the upcoming launch of its revolutionary new instrument for protein interaction analysis - the Fluidity One-W.
-
Awards, Press and media
Protein analysis technology recognised with high-profile awardFluidity One-W wins SLAS new product award for enabling in-solution interaction analysis of challenging proteins
-
Press and media, Events
Professor Sara Linse presents new data on protein interactions in Alzheimer’s disease using the Fluidity One-W at FEBS 2019Fluidic Analytics’ microfluidic diffusional sizing technology has been influential in a study that investigates protein binding and self-assembly in Alzheimer’s disease and was presented by Professor Sara Linse of Lund University, Sweden, at FEBS 2019, Krakow, Poland.
